RANKL inhibitors Essay
There has been a recent increase in the understanding of the role of bone remodeling that has opened possible therapeutic approaches that may yield new drugs for clinical use in the foreseeable future. RANKL inhibitors (e.g. the monoclonal antibody, denosumab). In a 2-page paper, explore the role of this class of medications in the management of osteoporosis. Discuss the current FDA approvals, if applicable, and the potential adverse events effects associated with this class of drugs. Additionally select a peer-reviewed research article (published within the last 5 years) related to this class of drugs and briefly summarize its findings.
Your paper should be double-spaced, with one-inch margins, 12 point “Times New Roman” font, and correctly follow APA formatting. Your thoughts and ideas should be supported by at least one scholarly research article on the topic. Please note all written assignments should contain in-text citations in accordance with APA format. A title and reference paper should be included as well. Save your assignment with the file name “Wk10Assign_YourLastName” as a Microsoft Word document and submit through the associated assignment link. please include a header
